U.S. Markets closed

Most Analysts Have Been Positive on Sage Therapeutics in March

Margaret Patrick
Most Analysts Have Been Positive on Sage Therapeutics in March

Analysts Are Feeling Good about These Biotech Stocks in March(Continued from Prior Part)Analysts’ recommendations and target priceWall Street analysts expect a potential upside of 26.25% for Sage Therapeutics (SAGE) based on the company’s